Business

GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter and full year 2025 following the close of market on Thursday, Feb. 19, 2026. Following the release, company management will host a webcast and conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss results and business progress.

articleGrail, Inc.February 16, 20262/company/grail-llc/news/grail-to-announce-fourth-quarter-and-full-year-2025-financial-results
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results

About this update from Grail, Inc.

[{"type":"text","content":"MENLO PARK, Calif., Feb. 16, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter and full year 2025 following the close of market on Thursday, Feb. 19, 2026. Following the release, company management will host a webcast and conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss results and business progress.","length":468,"tagName":"p"},{"type":"image","alt":"GRAIL, Inc. is a healthcare company whose mission is to detect cancer early when it can be cured. (PRNewsfoto/GRAIL, Inc.)","displaySize":"","headline":null,"caption":"GRAIL, Inc. is a healthcare company whose mission is to detect cancer early when it can be cured. (PRNewsfoto/GRAIL, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":76,"url":"https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LnMp0pobetiqZw3skecvAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEzNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf","width":400,"height":76}},"href":"https://mma.prnewswire.com/media/2460831/Grail_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Fourth Quarter and Full Year 2025 Webcast and Conference Call Details","length":69,"tagName":"p"},{"type":"text","content":"A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com.","length":145,"tagName":"p"},{"type":"text","content":"Please register for the live event at https://grail-q4-financial-results-2025.open-exchange.net/","length":96,"tagName":"p"},{"type":"text","content":"To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.","length":222,"tagName":"p"},{"type":"text","content":"About GRAIL","length":11,"tagName":"p"},{"type":"text","content":"GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, popul...

More updates from Grail, Inc.

GRAIL, Inc.GRAILhealthcare companyfinancial resultsfourth quarter